EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.773
https://www.valueinhealthjournal.com/article/S1098-3015(23)00873-2/fulltext
Title :
EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00873-2&doi=10.1016/j.jval.2023.03.773
First page :
Section Title :
Open access? :
No
Section Order :
10244